People
Caitlin Latimer
Dr. Caitlin Latimer is a neuropathologist and physician–scientist at the University of Washington whose research focuses on the molecular and cellular mechanisms of brain aging and age-related neurodegenerative diseases. She integrates human post-mortem brain tissue studies with advanced molecular tools and model systems to better understand the molecular drivers of poly-pathology in the aging brain. One major focus in the lab is mechanisms of tau and TDP-43 synergy in the context of Alzheimer’s disease, specifically interrogating how these pathologies synergize and impact cellular resilience in Alzheimer’s disease. Another research focus is understanding the basis of resilience—why some individuals maintain cognitive function despite significant neuropathology. By combining high-resolution spatial transcriptomics, quantitative neuropathology, and translational model systems including C. elegans and human cell cultures, Dr. Latimer’s lab aims to identify the cellular interactions and signaling pathways that contribute to disease risk and protection, with the ultimate goal of advancing biomarkers and therapeutic strategies for Alzheimer’s disease and related dementias.
Mamatha Damodarasamy
Nadia Postupna
Marika Bogdani
Marika Bogdani holds an MD and PhD.
Javier A. Ramos Benitez
Javier is a PhD candidate in the Latimer and Keene lab. He studies neuropathological disease by leveraging single cell and spatial technologies to characterize cell types and cell states.
Jordan Ogg
Jordan is a PhD candidate in the Latimer and Young Lab.
Madeline Valentine
Maddie is a PhD candidate in the Latimer and Young Lab.
Heino Hulsey-Vincent
Heino is a research scientist in the Latimer lab. He holds a Master's degree in Biology from Western Washington University.